Brief: Kazia Therapeutics Expands Ongoing Phase 1B Trial Of Paxalisib In Advanced Breast Cancer
26/05/2026 12:39
BRIEF-Kazia Therapeutics Expands Ongoing Phase 1B Trial Of Paxalisib In Advanced Breast Cancer May 26 (Reuters) - Kazia Therapeutics Ltd KZIA.O:
KAZIA THERAPEUTICS EXPANDS ONGOING PHASE 1B TRIAL OF PAXALISIB IN ADVANCED BREAST CANCER
KAZIA THERAPEUTICS LTD - PLANNED ENROLLMENT IN PHASE 1B TRIAL TO INCREASE FROM 12 TO 36 PATIENTS
Source text: ID:nPn6dzXPra
Further company coverage: KZIA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
Kazia drops on $40 mln equity offering to fund breast cancer drug
Kazia slides after breast cancer drug update, equity offering launch
Brief: Kazia Therapeutics Limited Announces Proposed Public Offering